Your browser is no longer supported. Please, upgrade your browser.
Settings
MEIP MEI Pharma, Inc. daily Stock Chart
MEIP [NASD]
MEI Pharma, Inc.
Index- P/E- EPS (ttm)-0.30 Insider Own0.40% Shs Outstand106.00M Perf Week19.05%
Market Cap358.26M Forward P/E- EPS next Y-0.35 Insider Trans33.94% Shs Float98.42M Perf Month50.21%
Income-24.50M PEG- EPS next Q0.26 Inst Own68.80% Short Float4.56% Perf Quarter59.09%
Sales4.50M P/S79.61 EPS this Y75.60% Inst Trans1.23% Short Ratio2.21 Perf Half Y95.53%
Book/sh0.70 P/B5.00 EPS next Y-76.90% ROA-27.60% Target Price- Perf Year12.54%
Cash/sh0.91 P/C3.86 EPS next 5Y-0.10% ROE-39.70% 52W Range0.72 - 3.64 Perf YTD41.13%
Dividend- P/FCF- EPS past 5Y29.50% ROI-96.50% 52W High-3.85% Beta1.87
Dividend %- Quick Ratio9.30 Sales past 5Y- Gross Margin27.50% 52W Low386.11% ATR0.24
Employees40 Current Ratio9.30 Sales Q/Q0.00% Oper. Margin- RSI (14)79.30 Volatility9.76% 8.62%
OptionableYes Debt/Eq0.00 EPS Q/Q83.20% Profit Margin- Rel Volume0.96 Prev Close3.51
ShortableYes LT Debt/Eq0.00 EarningsMay 07 BMO Payout- Avg Volume2.03M Price3.50
Recom1.70 SMA2023.03% SMA5064.59% SMA20075.92% Volume1,917,623 Change-0.28%
Dec-20-18Initiated H.C. Wainwright Buy $10
Dec-20-18Initiated H.C. Wainwright Buy
Jul-27-18Upgrade Stifel Hold → Buy $2.50 → $7
Jul-13-18Initiated SunTrust Buy $12
Apr-18-16Reiterated Wedbush Neutral $3 → $2
Mar-23-15Downgrade ROTH Capital Buy → Neutral $14 → $2.50
Dec-18-14Reiterated ROTH Capital Buy $22 → $14
Oct-16-14Reiterated ROTH Capital Buy $20 → $22
Jul-08-14Resumed Brean Capital Buy $16
Oct-22-13Reiterated Stifel Buy $11 → $15
Apr-15-13Initiated Stifel Buy $11
May-26-20 08:00AM  MEI Pharma to Host Investor and Analyst Video Webcast Following ASCO20 Virtual Scientific Program PR Newswire
May-21-20 08:36AM  How MEI Pharma (MEIP) Stock Stands Out in a Strong Industry Zacks
May-15-20 11:25AM  Top Ranked Momentum Stocks to Buy for May 15th Zacks
09:09AM  MEI Pharma, Inc. (MEIP) Shares March Higher, Can It Continue? Zacks
May-14-20 10:34AM  MEI Pharma and Kyowa Kirin Announces ME-401 Phase 1b Study to be Highlighted in a Presentation at the Virtual Edition of the 25th European Hematology Association Annual Congress PR Newswire
May-13-20 05:05PM  Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes PR Newswire
May-11-20 06:51AM  H.C. Wainwright Sticks to Their Buy Rating for MEI Pharma Investing.com +5.84%
May-09-20 10:25AM  MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Are Pretty Bullish On The Stock After Recent Results Simply Wall St.
May-07-20 07:06AM  MEI Pharma Reports Fiscal Third-Quarter 2020 Results and Recent Corporate Highlights PR Newswire
Apr-20-20 10:55AM  How Does MEI Pharma, Inc. (NASDAQ:MEIP) Affect Your Portfolio Volatility? Simply Wall St.
Apr-15-20 08:03AM  The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US Benzinga
Apr-14-20 01:00PM  MEI Pharma Appoints Cheryl Cohen, Product Launch and Commercialization Veteran, to its Board of Directors PR Newswire +49.70%
07:00AM  MEI Pharma and Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401 PR Newswire
07:00AM  MEI Pharma and Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401 Business Wire
Apr-08-20 08:00AM  MEI Pharma to Present at the 19th Annual Needham Virtual Healthcare Conference PR Newswire
Mar-31-20 08:00AM  MEI Pharma Announces Fast Track Designation Granted by U.S. FDA for ME-401 For the Treatment of Adult Patients with Relapsed or Refractory Follicular Lymphoma PR Newswire +11.81%
Mar-27-20 08:37AM  The Zacks Analyst Blog Highlights: Ensign, Gaia, MEI Pharma, Turning Point Brands and A10 Networks Zacks -16.77%
Mar-26-20 07:44AM  5 Top Stocks That Have Skyrocketed in the Past 7 Days Zacks +6.62%
Mar-13-20 09:04AM  Those Who Purchased MEI Pharma (NASDAQ:MEIP) Shares Five Years Ago Have A 81% Loss To Show For It Simply Wall St. -14.17%
Feb-18-20 09:46AM  The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma Zacks +7.71%
Feb-13-20 10:03AM  New Covid-19 Cases Increase, 5 Defensive Stocks to Buy Zacks
Feb-06-20 04:02PM  MEI Pharma Reports Fiscal Second-Quarter 2020 Results and Operational Highlights PR Newswire
09:39AM  Is MEI Pharma, Inc.'s (NASDAQ:MEIP) CEO Pay Fair? Simply Wall St.
Dec-31-19 08:58AM  MEI Pharma (MEIP) Catches Eye: Stock Jumps 8.1% Zacks +5.53%
Dec-29-19 09:40PM  Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus Benzinga
Dec-22-19 05:56PM  Weekly CFO Buys Highlight GuruFocus.com
Dec-19-19 11:45AM  MEI Pharma Announces Closing of Public Offering of Common Stock PR Newswire
Dec-17-19 08:01AM  MEI Pharma Announces Pricing of Public Offering of Common Stock PR Newswire -26.20%
Dec-16-19 04:01PM  MEI Pharma Announces Proposed Public Offering of Common Stock PR Newswire +13.37%
Dec-13-19 11:19AM  MEI Pharma Inc (NASDAQ:MEIP): Hedge Funds In Wait-and-See Mode Insider Monkey
Dec-09-19 01:25PM  We Think MEI Pharma (NASDAQ:MEIP) Can Afford To Drive Business Growth Simply Wall St.
Nov-12-19 08:00AM  MEI Pharma to Present at the Stifel 2019 Healthcare Conference PR Newswire
Nov-07-19 04:05PM  MEI Pharma Reports First Quarter Fiscal Year 2020 Results and Operational Highlights PR Newswire
Oct-24-19 11:17AM  Does MEI Pharma, Inc. (NASDAQ:MEIP) Have A High Beta? Simply Wall St.
Oct-04-19 07:32AM  The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering Benzinga
Oct-03-19 04:02PM  MEI Pharma Announces Updated Clinical Data from ME-401 Phase 1b Study in Patients with Indolent B-cell Malignancies PR Newswire +6.51%
Sep-23-19 08:00AM  MEI Pharma to Host Investor and Analyst Event on October 4, 2019 PR Newswire
Sep-18-19 10:55AM  A Holistic Look At MEI Pharma, Inc. (NASDAQ:MEIP) Simply Wall St.
Sep-14-19 01:34AM  Edited Transcript of MEIP earnings conference call or presentation 28-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-29-19 08:00AM  MEI Pharma to Present at the 2019 Wells Fargo Healthcare Conference PR Newswire
Aug-28-19 04:05PM  MEI Pharma Reports Fiscal Year 2019 Results and Operational Highlights PR Newswire +6.83%
07:31AM  The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved Benzinga
Aug-21-19 08:00AM  MEI Pharma to Release 2019 Fiscal Year End Financial Results and Provide Corporate Update on August 28, 2019 PR Newswire
Aug-13-19 11:56AM  What Did MEI Pharma, Inc.'s (NASDAQ:MEIP) CEO Take Home Last Year? Simply Wall St.
Jul-08-19 01:37PM  Imagine Owning MEI Pharma (NASDAQ:MEIP) While The Price Tanked 63% Simply Wall St.
Jul-03-19 08:00AM  MEI Pharma Appoints Longtime Industry Consultant and Executive Tamar Howson to its Board of Directors PR Newswire
Jun-23-19 04:13PM  Is MEI Pharma Inc (MEIP) A Good Stock To Buy? Insider Monkey
Jun-22-19 02:30AM  MEI Pharma Presents Updated Clinical Data from the ME-401 Phase 1b study in Patients with Indolent B-cell Malignancies at the 2019 International Conference on Malignant Lymphoma (ICML) PR Newswire
Jun-03-19 09:00AM  MEI Pharma Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab Phase 1b study in Patients with Follicular Lymphoma at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire
Jun-01-19 09:00AM  MEI Pharma Presents Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer Patients at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire
May-31-19 08:00AM  MEI Pharma to Present at the Jefferies 2019 Global Healthcare Conference PR Newswire
May-15-19 05:00PM  MEI Pharma to Present New Clinical Results on ME-401 and ME-344 Programs at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire
May-09-19 04:02PM  MEI Pharma Reports Third Quarter Fiscal Year 2019 Results and Operational Highlights PR Newswire
May-01-19 10:32AM  Earnings Preview: MEI Pharma (MEIP) Q3 Earnings Expected to Decline Zacks
Apr-28-19 10:54AM  How Does MEI Pharma, Inc. (NASDAQ:MEIP) Affect Your Portfolio Volatility? Simply Wall St.
Apr-12-19 04:52PM  2 Biotech Stock Picks From Legendary Investor Joseph Edelman GuruFocus.com
Apr-02-19 08:00AM  MEI Pharma to Present at the 18th Annual Needham Healthcare Conference PR Newswire
Mar-12-19 08:00AM  MEI Pharma to Present at the 29th Annual Oppenheimer Healthcare Conference PR Newswire
Feb-28-19 10:39AM  A Holistic Look At MEI Pharma, Inc. (NASDAQ:MEIP) Simply Wall St.
Feb-07-19 04:05PM  MEI Pharma Reports Second Quarter Fiscal Year 2019 Results and Operational Highlights PR Newswire
10:31AM  MEI Pharma (MEIP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jan-21-19 11:01AM  What Percentage Of MEI Pharma, Inc. (NASDAQ:MEIP) Shares Do Insiders Own? Simply Wall St.
Dec-03-18 01:32PM  Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting PR Newswire -5.90%
Dec-02-18 12:00PM  MEI Pharma Presents Clinical Data from Ongoing Phase 1b Study of ME-401 in Patients with Indolent B-Cell Malignancies at the 2018 American Society of Hematology Annual Meeting PR Newswire
Dec-01-18 12:00PM  MEI Pharma Presents Preclinical Data Demonstrating Voruciclib Synergistically Induces Apoptosis in Combination with Venetoclax in Acute Myeloid Leukemia Cells at the 2018 American Society of Hematology Annual Meeting PR Newswire
Nov-30-18 01:21PM  Is MEI Pharma Incs (NASDAQ:MEIP) CEO Paid At A Competitive Rate? Simply Wall St.
Nov-19-18 08:10AM  Market Trends Toward New Normal in Lightbridge, MEI Pharma, Good Times Restaurants, Lilis Energy, Microbot Medical, and S&W Seed Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire -9.90%
Nov-12-18 05:45AM  MEI Pharma Sees Hammer Chart Pattern: Time to Buy? Zacks -6.10%
Nov-08-18 04:00PM  MEI Pharma Reports First Quarter Fiscal Year 2019 Results and Operational Highlights PR Newswire
Nov-07-18 10:30AM  Will MEI Pharma (MEIP) Report Negative Earnings Next Week? What You Should Know Zacks
Nov-06-18 08:00AM  MEI Pharma To Present at Stifel 2018 Healthcare Conference PR Newswire
Nov-05-18 08:00AM  MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan PR Newswire
Nov-02-18 08:37AM  Implied Volatility Surging for MEI Pharma (MEIP) Stock Options Zacks
Nov-01-18 09:00AM  MEI Pharma to Present Clinical Data from Three Oncology Programs at the 2018 American Society of Hematology (ASH) Annual Meeting PR Newswire
Oct-11-18 06:42AM  BRIEF-MEI Pharma And Beigene Announce Clinical Collaboration Reuters +8.71%
06:00AM  MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies PR Newswire
Sep-20-18 11:55AM  What does MEI Pharma Incs (NASDAQ:MEIP) Balance Sheet Tell Us About Its Future? Simply Wall St.
Sep-10-18 03:21AM  Edited Transcript of MEIP earnings conference call or presentation 30-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-31-18 08:00AM  Today's Research Reports on Trending Tickers: Sangamo Therapeutics and MEI Pharma ACCESSWIRE -6.90%
Aug-30-18 04:05PM  MEI Pharma Reports Fiscal Year 2018 Results and Operational Highlights PR Newswire +5.65%
03:00PM  MEI Pharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-29-18 08:38AM  Should You Buy MEI Pharma (MEIP) Ahead of Earnings? Zacks
08:00AM  MEI Pharma To Present at Wells Fargo Securities 2018 Healthcare Conference PR Newswire
Aug-23-18 08:00AM  MEI Pharma to Release 2018 Fiscal Year End Financial Results and Provide Corporate Update on August 30, 2018 PR Newswire
Jul-30-18 07:10AM  Initiating Free Research Reports on Synergy Pharma and Three Other Drug Makers Equities ACCESSWIRE
Jul-27-18 10:29AM  Stifel Doubles Down On MEI Pharma, Considers ME-401 'Best-In-Class' Benzinga +6.55%
Jul-16-18 08:00AM  MEI Pharma Promotes David M. Urso to Chief Operating Officer PR Newswire
Jun-28-18 07:35AM  Initiating Free Research Reports on Canopy Growth and Three Other Drug Makers Equities ACCESSWIRE
Jun-15-18 08:00AM  MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress PR Newswire
Jun-11-18 08:00AM  MEI Pharma, Partnerships, Well-Funded Clinical Programs and Promising Clinical Data Driving Oncology Research GlobeNewswire
Jun-04-18 08:01AM  MEI Pharma Presents Phase 1b Clinical Data for ME-401 in Patients with Indolent B-Cell Malignancies at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire
08:00AM  MEI Pharma Presents Clinical Data for ME-344 in HER2 Negative Breast Cancer Patients at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire
May-31-18 08:30AM  MEI Pharma and Helsinn Group Announce Successful Interim Analysis of Pracinostat/Azacitidine Phase 2 Combination Study in Higher Risk Myelodysplastic Syndrome (MDS) Patients PR Newswire
May-16-18 05:00PM  MEI Pharma to Present Clinical Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire
May-14-18 08:00AM  MEI Pharma Announces $75 Million Private Placement PR Newswire +13.45%
May-09-18 08:30AM  MEI Pharma Reports Third Quarter Fiscal Year 2018 Results PR Newswire
Mar-14-18 08:00AM  MEI Pharma To Present at Two Upcoming Investor Conferences PR Newswire
Feb-26-18 08:00AM  MEI Pharma Appoints Industry Veteran Frederick W. Driscoll to its Board of Directors PR Newswire
Feb-13-18 08:00AM  MEI Pharma Interim Data Review Supports Continuation of Clinical Study Evaluating ME-344 in Patients with Breast Cancer PR Newswire
Feb-08-18 08:00AM  MEI Pharma Reports Second Quarter Fiscal Year 2018 Results PR Newswire -6.44%
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company's clinical drug candidate includes Pracinostat, an oral available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia (AML) and myelodysplastic syndrome. Its clinical development portfolio also includes ME-401, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with relapsed/refractory follicular lymphoma and B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase inhibitor for B-cell malignancies and AML. In addition, the company engages in the development of ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex for the treatment of HER2-negative breast cancer. MEI Pharma, Inc. has a license, development, and commercialization agreement with Helsinn Healthcare SA for the development, manufacture, and commercialization of Pracinostat; and a license agreement with Presage Biosciences, Inc. to develop, manufacture, and commercialize Voruciclib, a clinical-stage, oral, and selective cyclin-dependent kinase inhibitor, as well as related compounds. The company also has a license agreement with CyDex Pharmaceuticals, Inc. for Captisol to use with ME-344, which are isoflavone-based drug compounds; a clinical collaboration agreement with BeiGene, Ltd. to evaluate the safety and efficacy of ME-401 in combination with BeiGene's zanubrutinib, an investigational BTK inhibitor for the treatment of patients with B-cell malignancies; and a license agreement with Kyowa Kirin Co., Ltd. for ME-401. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was founded in 2000 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reynolds Thomas CDirectorDec 19Buy1.6010,00016,00010,000Dec 20 12:57 PM
DRISCOLL FREDERICK WDirectorDec 19Buy1.6062,500100,00062,500Dec 20 12:56 PM
GOLD DANIEL P PHDChief Executive OfficerDec 19Buy1.6018,75030,000361,632Dec 20 12:54 PM
Drazba Brian G.Chief Financial OfficerDec 19Buy1.6012,50020,00037,500Dec 20 12:55 PM
GOLD DANIEL P PHDChief Executive OfficerSep 27Option Exercise1.5720,00031,400342,882Oct 01 12:04 PM
White Christine AnnaDirectorSep 06Buy1.7415,00026,07515,000Sep 09 04:52 PM